Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > "$3 billion in debt, less than $800 million in sales...."
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by cg16on Oct 22, 2016 7:34pm
112 Views
Post# 25374839

RE:RE:RE:"$3 billion in debt, less than $800 million in sales...."

RE:RE:RE:"$3 billion in debt, less than $800 million in sales...."S2Zero2, do you know what Marc Cohedes meant when he said "...one last time" in the tweet you copied over 
to your SH post? 

"Heard from some fascinating people today. They had to manipulate Concordia stock one last time into the Swan Dive. Just perfect GLTA"
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities